These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2995505)
21. Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir. Agut H; Huraux JM; Collandre H; Montagnier L Lancet; 1989 Sep; 2(8663):626. PubMed ID: 2570323 [No Abstract] [Full Text] [Related]
22. A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate. Biron KK; Fyfe JA; Stanat SC; Leslie LK; Sorrell JB; Lambe CU; Coen DM Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8769-73. PubMed ID: 3022304 [TBL] [Abstract][Full Text] [Related]
23. Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient mice. Smee DF; Sugiyama ST; Reist EJ Antimicrob Agents Chemother; 1994 Sep; 38(9):2165-8. PubMed ID: 7811037 [TBL] [Abstract][Full Text] [Related]
24. Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein. Michel D; Höhn S; Haller T; Jun D; Mertens T J Med Virol; 2001 Sep; 65(1):70-6. PubMed ID: 11505446 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of murine cytomegalovirus lung infection and interstitial pneumonitis by acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Shanley JD; Morningstar J; Jordan MC Antimicrob Agents Chemother; 1985 Aug; 28(2):172-5. PubMed ID: 3010835 [TBL] [Abstract][Full Text] [Related]
26. Screening with a shell vial assay for antiviral activity against cytomegalovirus. Telenti A; Smith TF Diagn Microbiol Infect Dis; 1989; 12(1):5-8. PubMed ID: 2540934 [TBL] [Abstract][Full Text] [Related]
27. Selenoacyclovir and Selenoganciclovir: Discovery of a New Template for Antiviral Agents. Sahu PK; Umme T; Yu J; Nayak A; Kim G; Noh M; Lee JY; Kim DD; Jeong LS J Med Chem; 2015 Nov; 58(21):8734-8. PubMed ID: 26460883 [TBL] [Abstract][Full Text] [Related]
28. Interaction of 9-(1,3-dihydroxy-2-propoxymethyl)guanine with cytosol and mitochondrial deoxyguanosine kinases: possible role in anti-cytomegalovirus activity. Smee DF Mol Cell Biochem; 1985 Nov; 69(1):75-81. PubMed ID: 3001505 [TBL] [Abstract][Full Text] [Related]
29. Successful treatment of murine cytomegalovirus disease does not prevent latent virus infection. Katzenstein DA; Crane RT; Jordan MC J Lab Clin Med; 1986 Aug; 108(2):155-60. PubMed ID: 3016127 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline. Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413 [TBL] [Abstract][Full Text] [Related]
32. Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir. McSharry JJ; McDonough A; Olson B; Hallenberger S; Reefschlaeger J; Bender W; Drusano GL Antimicrob Agents Chemother; 2001 Oct; 45(10):2925-7. PubMed ID: 11557492 [TBL] [Abstract][Full Text] [Related]
33. Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine. Akula SK; Mansell PW; Ruiz R Am J Ophthalmol; 1986 May; 101(5):622. PubMed ID: 3010726 [No Abstract] [Full Text] [Related]
34. Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication. Tocci MJ; Livelli TJ; Perry HC; Crumpacker CS; Field AK Antimicrob Agents Chemother; 1984 Feb; 25(2):247-52. PubMed ID: 6324669 [TBL] [Abstract][Full Text] [Related]
35. The folate antagonist, methotrexate, is a potent inhibitor of murine and human cytomegalovirus in vitro. Shanley JD; Debs RJ Antiviral Res; 1989 Mar; 11(2):99-106. PubMed ID: 2543289 [TBL] [Abstract][Full Text] [Related]
36. CMV retinitis treated with ganciclovir [9(1,3-dihydroxy-2-propoxymethyl) guanine] in patients with AIDS. Bach MC; Hedstrom PS Ann Ophthalmol; 1987 Oct; 19(10):369-73,375. PubMed ID: 2825580 [TBL] [Abstract][Full Text] [Related]
37. Effect of combinations of difluoromethylornithine (DFMO) and 9[(1,3-dihydroxy-2-propoxy) methyl]guanine (DHPG) on human cytomegalovirus. Rush J; Mills J J Med Virol; 1987 Mar; 21(3):269-76. PubMed ID: 3031202 [TBL] [Abstract][Full Text] [Related]
38. Treatment of cytomegalovirus retinitis in a patient with AIDS with 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Macdonald EA Can J Ophthalmol; 1987 Feb; 22(1):48-52. PubMed ID: 3028588 [TBL] [Abstract][Full Text] [Related]
39. Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase. Smee DF; Knight SS; Duke AE; Robinson WS; Matthews TR; Marion PL Antimicrob Agents Chemother; 1985 Feb; 27(2):277-9. PubMed ID: 2580482 [TBL] [Abstract][Full Text] [Related]